Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 303
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07857759 Cervical Lymphatic Microsurgery in Alzheimer's Disease |
Cervical Lymphatic Microsurgery | Alzheimer | Non applicable | RECRUITING | En attente / non publié | Daniel Maliszewski | Poland · Uniwersyteckie Centrum Kliniczne w Gdansku, … | 2026-09 → 2029-05 | Ouvrir |
| NCT06052254 Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Asso… |
12 cm2 - 2 Active DMTS Patches | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | Teikoku Pharma USA, Inc. | United States · Arrow Clinical Trials, Daytona Beach,… | 2025-09-16 → 2027-05 | Ouvrir |
| NCT07843459 A Study of LY4560736 in Healthy Participants and Participants With Alzh… |
LY4560736 | Alzheimer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Eli Lilly and Company | United States, China, Japan · Accel Research Sites - … | 2026-10 → 2028-07 | Ouvrir |
| NCT07866768 CMN LIFU for Enhanced Glymphatic Clearance in Amyloid-Positive MCI |
ATTN201 Focused Ultrasound to the… | Alzheimer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of California, San Fra… | United States · University of California San Francisc… | 2026-09 → 2028-01 | Ouvrir |
| NCT07869238 NMSBBBOYUSH01 — Pilot Clinical Trial to Assess the Safety of NMS-01 in … |
NMS-01 | Alzheimer | Non applicable | RECRUITING | En attente / non publié | Neumous Inc. | South Korea · Severance Hospital, Seoul, South Korea | 2026-01-05 → 2026-11-30 | Ouvrir |
| NCT02681172 Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients Wi… |
Neuraceq (florbetaben 18F) | Alzheimer | Phase 4 | COMPLETED | En attente / non publié | Lantheus Biosciences Ltd. | France · Coordinating center (Hôpital de La Timone) a… | 2015-10 → 2016-11 | Ouvrir |
| NCT07787169 A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Heal… |
LY4405094 | Alzheimer | Phase 1 | RECRUITING | En attente / non publié | Eli Lilly and Company | United States, China, Japan · Accel Research Sites - … | 2026-09-09 → 2028-07 | Ouvrir |
| NCT07033494 A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (M… |
MK-2214 | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Belgium, Canada,… | 2025-07-16 → 2030-04-30 | Ouvrir |
| NCT07721467 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilo… |
Psilocybin | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | National Institute on Aging (NIA) | United States · National Institute of Aging, Clinical… | 2026-10-14 → 2030-12-31 | Ouvrir |
| NCT07169630 PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer … |
18F-PF974 | Alzheimer | Phase 1 | RECRUITING | En attente / non publié | National Institute of Mental Heal… | United States · National Institutes of Health Clinica… | 2026-10-14 → 2030-04-11 | Ouvrir |
| NCT04770220 APOLLOE4 — An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD … |
Experimental: ALZ-801 | Alzheimer | Phase 3 | COMPLETED | En attente / non publié | Alzheon Inc. | United States, Canada, Czechia, France, Germany, Icel… | 2021-05-19 → 2024-07-29 | Ouvrir |
| NCT05980949 Open-Label Extension Study to Assess the Long-Term Safety and Tolerabil… |
KarXT | Alzheimer | Phase 3 | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Argentina, Belgium, Brazil, Bulgaria, … | 2023-07-11 → 2027-09-07 | Ouvrir |
| NCT05834296 Study in Subjects With Mild-to-Moderate Alzheimer's Dementia |
ALZN002 (autologous DCs pulsed wi… | Alzheimer | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Alzamend Neuro, Inc. | United States · First Excellent Research Group, Doral… | 2023-07-05 → 2028-03-03 | Ouvrir |
| NCT05543681 CALMA — Clinical Trial on Agitation in Alzheimer's Dementia |
IGC-AD1-Active | Alzheimer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | IGC Pharma, LLC | United States, Canada, Puerto Rico · Baycrest Academy… | 2022-10-11 → 2026-11 | Ouvrir |
| NCT07667478 NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DIS… |
Repetitive Transcranial Magnetic … | Alzheimer | Non applicable | RECRUITING | En attente / non publié | Chi-Ying (Roy) Lin | United States · Baylor College of Medicine, Houston, … | 2026-04-15 → 2031-04-14 | Ouvrir |
| NCT07854327 LymphDAD — Restoring Cervical Lymphatic Drainage in Alzheimer's Disease |
Cervical lymphovenous anastomosis… | Alzheimer | Non applicable | RECRUITING | En attente / non publié | University of Siena | Italy · Azienda Ospedaliera Universitaria Le Scotte, … | 2026-07-01 → 2028-12-31 | Ouvrir |
| NCT05326750 Non-invasive Neurostimulation as a Tool for Diagnostics and Management … |
Gamma tACS (40 Hz) over the super… | Alzheimer | Non applicable | RECRUITING | En attente / non publié | Kuopio University Hospital | Finland · Kuopio University Hospital, Kuopio, Finland | 2022-11-21 → 2032-07 | Ouvrir |
| NCT06887192 A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatme… |
ML-007C-MA | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | MapLight Therapeutics | United States, Argentina, Bulgaria, Canada, Chile, Cz… | 2025-08-15 → 2027-12 | Ouvrir |
| NCT07142278 DU-PRISM — DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid… |
DUVAX 200 µg | Alzheimer | Phase 1 | RECRUITING | En attente / non publié | Nuravax, Inc. | United States · Palm Springs Community Health Center,… | 2026-09-25 → 2027-07-31 | Ouvrir |
| NCT07579884 To Evaluate the Safety and Efficacy of RP902 Tablets |
RP902 | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | Risen (Suzhou) Pharma Tech Co., L… | China · Beijing Tiantan Hospital, Capital Medical Uni… | 2026-07-14 → 2031-05 | Ouvrir |
| NCT07756294 REVITAA-ALZ — Restoring Vascular and Insulin Function To Augment Anti-A… |
Empagliflozin | Alzheimer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Wake Forest University Health Sci… | United States · Wake Forest Alzheimer's Disease Resea… | 2026-11 → 2028-04 | Ouvrir |
| NCT06189963 Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disea… |
SNK01 | Alzheimer | Phase 1/2 | RECRUITING | En attente / non publié | NKGen Biotech, Inc. | United States, Canada · AdventHealth Research Institu… | 2023-11-21 → 2028-06 | Ouvrir |
| NCT06113640 Montelukast in Parkinson Disease |
levodopa-carbidopa | Parkinson | Phase 2/3 | COMPLETED | En attente / non publié | Mostafa Bahaa | Egypt · Faculty of Medicine, Tanta University, Tanta,… | 2023-11-05 → 2026-08-20 | Ouvrir |
| NCT07651319 Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease |
IL-2 (Aldesleukin) | Alzheimer | Phase 1/2 | RECRUITING | En attente / non publié | The Methodist Hospital Research I… | United States · Houston Methodist Research Institute,… | 2026-09-01 → 2029-12 | Ouvrir |
| NCT05667649 Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Dire… |
RB-ADSC | Alzheimer | Phase 1 | COMPLETED | En attente / non publié | Regeneration Biomedical, Inc. | United States · Hoag Memorial Hospital Presbyterian, … | 2023-08-14 → 2026-06-25 | Ouvrir |